These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9386250)

  • 1. Use of sustained release vehicles in the treatment of Meniere's disease.
    Hoffer ME; Balough B; Henderson J; DeCicco M; Wester D; O'Leary MJ; Kopke R
    Otolaryngol Clin North Am; 1997 Dec; 30(6):1159-66. PubMed ID: 9386250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intratympanic gentamycin in association with human fibrin glue in the treatment of Meniere's disease: preliminary results].
    Casani AP; Dallan I; Sellari-Franceschini S; Nuti D
    Acta Otorhinolaryngol Ital; 2002 Aug; 22(4):199-207. PubMed ID: 12379040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic use of aminoglycosides in Ménière's disease.
    Monsell EM; Cass SP; Rybak LP
    Otolaryngol Clin North Am; 1993 Oct; 26(5):737-46. PubMed ID: 8233486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G; Maurer J; Mann W
    Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocochleography and gentamicin therapy for Ménière's disease: a preliminary report.
    Adamonis J; Stanton SG; Cashman MZ; Mattan K; Nedzelski JM; Chen JM
    Am J Otol; 2000 Jul; 21(4):534-42. PubMed ID: 10912700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK; Sandooram D; Prinsley PR
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
    Perez N; Martin E; Zubieta JL; Romero MD; Garcia-Tapia R
    Laryngoscope; 2002 Jun; 112(6):1104-9. PubMed ID: 12160282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
    J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin.
    Enrique-Gonzaleza A; Sánchez-Ferrándiz N; Pérez-Fernández N
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):249-54. PubMed ID: 19408504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summating potential and action potential ratio in Meniere's disease before and after treatment.
    Orchik DJ; Shea JJ; Ge NN
    Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.